References + Milestones
Our references and milestones clearly reflect many years of experience
For 30 years Polypharma has been successfully supporting generic drug manufacturers in various countries in Africa and the Middle East and ensuring their supply of raw materials (APIs).
We have registered more than 200 dossiers covering a wide range of therapeutic treatments and all pharmaceutical forms.
Polypharma is EUDRA-GMDP and ISO 9001 certified and ensures compliance with quality standards such as ICH guidelines, GMP, Pharmacopoeia and DMF.
Benefit from reliable dossiers
Over the years we have acquired knowledge of the regulatory requirements in various countries. We put this knowledge at generic manufacturers’ disposal and assist them until they obtain marketing authorisation.
If you’d like to expand your generic product range or set up a pharmaceutical company, turn pharmaceutical possibilities into realities: Contact us.
A large number of dossiers including all pharmaceutical forms developed by Polypharma and registered by our partners
Polypharma celebrates 30th anniversary
2018 - 2020
Establishment of a new pharmaceutical factory in Algeria
Focus on the development of new dossiers for dry forms, such as tablets, capsules and dry powder inhaler
Registration of first corticoid dossiers by our partners
First dossiers developed with anaesthetics in dual and triple therapy
Polypharma adds to its activities the exclusive representation of a HPLC columns producer for Germany and North Africa
Development of new corticoid dossiers in the form of tablets and oral solutions
Focus on the development of technical dossiers in the field of dual and triple therapies
Expansion of the product portfolio to include veterinary dossiers
Polypharmas first time as exhibitor at the fair CPhI Worldwide
Development of quinolone antibiotics in tablet form
Creation of dossiers with neuroleptics as suppositories and tablets as well as development of the first corticoid cream
Expansion of the private pharmaceutical sector in Algeria
North Africa: first market approvals of eye and nose drops by our partners
Development of the first dossiers for ophthalmic and nasal solutions as well as new technical dossiers for capsules.
First creation of β-lactam antibiotics in powder form to produce oral suspension
Expansion of the portfolio of cardiovascular dossiers
Morocco: first market approvals of Polypharma dossiers by partners
At the same time, a Tunisian pharmaceutical company registers antihistamine generics dossiers
Tunisia: registration of the first dossiers with Pseudoephedrine, injectable solutions and a first anti-haemorrhoid cream
Polypharma creates dossiers for dual and triple therapy (antiarrhythmic & cardiovascular) as well as anti-diabetic drugs
Obtain approval for the commercialisation of Narcotics and Category I Precursors, beginning with the first deliveries
Participation in a project to build a Learning Centre in Burundi
Registration of first Polypharma dossiers
Development of vaginal suppositories, suspensions, syrups and injectable solutions
Development of dossiers for dry, pastes and semi-solid dosage forms
Change of name to Polypharma Technologies & Sciences GmbH
Expansion of business area to include the development of generic drug dossiers and DMFs
Foundation of the company Polypharma Import Export GmbH
Resumption and development of trade relations previously established in various countries in Africa and the Middle East.
In the years preceding the creation of Polypharma, its founder gained experience in accompanying, among others, the following projects:
supervision of the reorganisation of a pharmaceutical factory, setting up a production line for infusion and a first local production line for generic syrups and tablets for the battle against malaria.
support during the production of various finished products in various pharmaceutical forms.
Burundi and Rwanda:
implementation of generic antimalarial drugs and macrolide antibiotics
assistance in production, registration of technical dossiers and realisation of several finished products in different sites
manufacturing of various pharmaceutical products